Drs Aide Vega and Fernando Carnavali highlight the increased control in both diabetes and kidney function with the use of KidneyIntelX in patients with DKD.
It is critical for physicians to urge patients with obesity to get vaccinated against COVID-19 as they are one of the highest risk patient populations.
At the 2023 American Thoracic Society International Conference a symposium focused on common comorbidities seen with COPD, their management, and research needs.
Experts discuss key takeaways from the review article “Role of Bempedoic Acid in Clinical Practice”, clinical implications, and the greatly anticipated CLEAR Outcomes trial.
These tips from a family physician on managing misinformation in the exam room can help reduce the spread of false and misleading narratives.
Since 2014, the age-adjusted mortality rate for diabetes and CVD has increased by 1% after an overall decline between 1999 and 2019, new research finds.
Obesity affects nearly 20% of US children, impacting both current and future health. The 2020 update of the Pediatric Obesity Algorithm provides expert treatment guidance.
Students from the Medical College of Georgia, unable to care directly for COVID-19 patients, combined their individual skills to keep accurate information flowing.
The first biosimilar to the approved formulation of natalizumab is indicated for relapsing forms of MS and for induction/maintenance of remission in adults with Crohn disease.
What does the latest research say about the association between mental health and cardiovascular disease? Scroll through our quick slideshow for an overview.
Nearly half of responding medical professionals said patients without T2D have asked for an Ozempic Rx and about 18% of them have provided one, avoiding significant backlash for a denial.
Mental health issues among health care professionals have always been normal; now that we can acknowledge them, we must, says a family physician and wellness advocate.
An obesity specialist explains why clinicians should start at the root cause when managing patients with type 2 diabetes and obesity.
The class of GLP-1 receptor agonists and similar agents, originally approved to treat type 2 diabetes, also reduce body weight and reduce CVD risk; what's next?
The Alzheimer's Association chief science officer discusses release of updated diagnostic guidelines for AD, which incorporate use of plasma-based biomarkers.
Wade Brosius, DO, Shelton Hager, MD, and Steven Peskin, MD, answer questions relating to diabetic retinopathy screening devices and highlight novel technologies utilized in this space.
Wade Brosius, DO, Shelton Hager, MD, and Steven Peskin, MD, answer questions relating to diabetic retinopathy screening devices and highlight novel technologies utilized in this space.
Parent's stigmatizing beliefs about the HPV vaccine may keep them from communicating openly with teens' clinicians, creating barriers to getting shots in arms.
Social determinants of health vary between patients living in different environments, so what are the key factors to consider when creating a treatment plan?
AHA Scientific Sessions 2021 recap, tests of clinical knowledge, expert interviews, and more in this roundup from Patient Care Online.
Jacinda Abdul-Mutakabbir, PHARMD, MPH, AAHIVP, leads a conversation on the importance of vaccination in the defense and protection against viral infections, such as the flu.
Pockets of positive tests for influenza A(H3N2), including on college campuses, may herald the opening of the 2021-2022 flu season.
The pandemic has altered how patients access and use health care. Now is the time for primary care clinicians to rebuild important connections with them.
Consider all the first year medical students introduced to patient care in 2020 via computer screens and monitors. A young telehealth native tells her story.
Women with PCOS and T2D in pregnancy were at greater risk for high insulin requirements, excess weight gain, and worsening of pregestation hypertension if treated with metformin.
Dr Diana Isaacs provides insight on current challenges in the clinical treatment of patients with diabetes and shares clinical pearls for the use of CGMs in disease management.
For the 1 in 3 individuals with hyperlipidemia who can't or won't take a statin, preventive cardiologist Elizabeth Klodas, MD, details 3 alternative drug classes.
Eden Miller, DO, shares key takeaways on how personalized treatment helps in the management of diabetes.